Similar articles

• Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies.

  Zhang T, Zhai M, Ji J, Zhang J, Tian Y, Liu X. Zhang T, et al. Bioorg Med Chem Lett. 2017 Jun 1;27(11):2364-2368. doi: 10.1016/j.bmcl.2017.04.028. Epub 2017 Apr 12. Bioorg Med Chem Lett. 2017. PMID: 28462833
• Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

  Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna, Kighoma PM, Koundouno FR, Réné Lolamou, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fiz… See abstract for full author list ➔ Sissoko D, et al. PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar. PLoS Med. 2016. PMID: 26930627 Free PMC article. Clinical Trial.
• Favipiravir: a new medication for the Ebola virus disease pandemic.

  Nagata T, Lefor AK, Hasegawa M, Ishii M. Nagata T, et al. Disaster Med Public Health Prep. 2015 Feb;9(1):79-81. doi: 10.1017/dmp.2014.151. Epub 2014 Dec 29. Disaster Med Public Health Prep. 2015. PMID: 25544306
• Current status of chemically synthesized inhibitors of Ebola virus.

  Cardile AP, Mayers DL, Bavari S. Cardile AP, et al. Recent Pat Antiinfect Drug Discov. 2014;9(2):97-103. doi: 10.2174/1574891x10666150326114221. Recent Pat Antiinfect Drug Discov. 2014. PMID: 25808170 Review.
• Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.

  Lee JS, Adhikari NKJ, Kwon HY, Teo K, Siemieniuk R, Lamontagne F, Chan A, Mishra S, Murthy S, Kiiza P, Hajek J, Bah EI, Lamah MC, Kao R, Fowler RA. Lee JS, et al. BMC Infect Dis. 2019 May 2;19(1):376. doi: 10.1186/s12879-019-3980-9. BMC Infect Dis. 2019. PMID: 31046707 Free PMC article.